Literature DB >> 30737282

Structural and functional definition of a vulnerable site on the hemagglutinin of highly pathogenic avian influenza A virus H5N1.

Pengfei Wang1, Yanan Zuo2, Jianfeng Sun1, Teng Zuo2, Senyan Zhang1, Shichun Guo3, Xuanling Shi2, Mifang Liang4, Paul Zhou5, Linqi Zhang6, Xinquan Wang7.   

Abstract

Most neutralizing antibodies against highly pathogenic avian influenza A virus H5N1 recognize the receptor-binding site (RBS) on the globular head domain and the stem of H5N1 hemagglutinin (HA). Through comprehensive analysis of multiple human protective antibodies, we previously identified four vulnerable sites (VS1-VS4) on the globular head domain. Among them, the VS1, occupying the opposite side of the RBS on the same HA, was defined by the epitope of antibody 65C6. In this study, we report the crystal structures of two additional human H5N1 antibodies isolated from H5N1-infected individuals, 3C11 and AVFluIgG01, bound to the head at 2.33- and 2.30-Å resolution, respectively. These two new antibody epitopes have large overlap with and extend beyond the original VS1. Site-directed mutagenesis experiments identified eight pivotal residues (Ser-126b, Lys-165, Arg-166, Ser-167, Tyr-168, Asn-169, Thr-171, and Asn-172) critical for 65C6-, 3C11-, and AVFluIgG01-binding and neutralization activities. These residues formed a unique "Y"-shaped surface on H5N1 globular head and are highly conserved among H5N1 viruses. Our results further support the existence of a vulnerable site distinct from the RBS and the stem region of H5N1 HA, and future design of immunogens should take this particular site into consideration.
© 2019 Wang et al.

Entities:  

Keywords:  H5N1; HPAI; X-ray crystallography; epitope; infectious disease; influenza; influenza virus; monoclonal antibody; mutagenesis; neutralizing antibody; structural biology; vaccine development; virology; vulnerable site

Mesh:

Substances:

Year:  2019        PMID: 30737282      PMCID: PMC6433081          DOI: 10.1074/jbc.RA118.007008

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

2.  Treatment with convalescent plasma for influenza A (H5N1) infection.

Authors:  Boping Zhou; Nanshan Zhong; Yi Guan
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

3.  Unraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutinin.

Authors:  Mengran Qian; Hongxing Hu; Teng Zuo; Guiqin Wang; Linqi Zhang; Paul Zhou
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

4.  Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.

Authors:  E C Claas; A D Osterhaus; R van Beek; J C De Jong; G F Rimmelzwaan; D A Senne; S Krauss; K F Shortridge; R G Webster
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

5.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

6.  Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants.

Authors:  Nikolai V Kaverin; Irina A Rudneva; Natalia A Ilyushina; Natalia L Varich; Aleksandr S Lipatov; Yuri A Smirnov; Elena A Govorkova; Asya K Gitelman; Dmitri K Lvov; Robert G Webster
Journal:  J Gen Virol       Date:  2002-10       Impact factor: 3.891

7.  A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.

Authors:  Ebony Benjamin; Weijia Wang; Josephine M McAuliffe; Frances J Palmer-Hill; Nicole L Kallewaard; Zhongying Chen; JoAnn A Suzich; Wade S Blair; Hong Jin; Qing Zhu
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

8.  Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors.

Authors:  Shinya Yamada; Yasuo Suzuki; Takashi Suzuki; Mai Q Le; Chairul A Nidom; Yuko Sakai-Tagawa; Yukiko Muramoto; Mutsumi Ito; Maki Kiso; Taisuke Horimoto; Kyoko Shinya; Toshihiko Sawada; Makoto Kiso; Taiichi Usui; Takeomi Murata; Yipu Lin; Alan Hay; Lesley F Haire; David J Stevens; Rupert J Russell; Steven J Gamblin; John J Skehel; Yoshihiro Kawaoka
Journal:  Nature       Date:  2006-11-16       Impact factor: 49.962

9.  A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus.

Authors:  Ying Wu; MyungSam Cho; David Shore; Manki Song; JungAh Choi; Tao Jiang; Yong-Qiang Deng; Melissa Bourgeois; Lynn Almli; Hua Yang; Li-Mei Chen; Yi Shi; Jianxu Qi; An Li; Kye Sook Yi; MinSeok Chang; Jin Soo Bae; HyunJoo Lee; JiYoung Shin; James Stevens; SeoungSuh Hong; Cheng-Feng Qin; George F Gao; Shin Jae Chang; Ruben O Donis
Journal:  Nat Commun       Date:  2015-07-21       Impact factor: 14.919

10.  Complementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodies.

Authors:  Yanan Zuo; Pengfei Wang; Jianfeng Sun; Shichun Guo; Guiqin Wang; Teng Zuo; Shilong Fan; Paul Zhou; Mifang Liang; Xuanling Shi; Xinquan Wang; Linqi Zhang
Journal:  J Biol Chem       Date:  2018-08-28       Impact factor: 5.157

View more
  1 in total

Review 1.  Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus.

Authors:  Yun Zhang; Cong Xu; Hao Zhang; George Dacai Liu; Chunyi Xue; Yongchang Cao
Journal:  Viruses       Date:  2019-04-30       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.